# Your page scores 74 out of 100 for sameness against the 2 competitors you named.

Most of what your page says, Infinitus says too — the overlap is heaviest in the benefits you promise.

- **Your page:** https://therxassistant.com/
- **Compared against:** Ostro (Veeva) (ostro.veeva.com), Infinitus (infinitus.ai)
- **Sameness Index:** 74 — Mostly the same
- **Ownable share:** 6% (of 56% distinctive)
- **Report:** https://grader.wynter.com/c/therxassistant-com-YdXW4Lw

**How you compare · vs 366 SaaS sites** — 18 points more same than the average SaaS site. The average SaaS site scores 56; you scored 74. You are less same than 29 of the 366 SaaS sites. The best-differentiated site in the set is at 6.
_A single check can move several points between runs; the benchmark averages up to eight sites per category._

> With 2 competitors, commonness can only take 3 distinct values. The figures are honest at that resolution and no finer.

## 1. Sameness Index

| Category | Weight | Score | What it means |
| --- | --- | --- | --- |
| Messaging | 30% | 78 | The most expensive kind of sameness. A buyer cannot tell what job you do that the others do not. |
| Claims | 30% | 100 | Every shared claim is a line already read on another tab. Cut the ones nobody owns and spend the space on something they cannot. |
| Features | 15% | 66 | Expected in a mature category, and the least alarming of the six. Feature parity is normal; leading with it is the mistake. |
| Proof | 10% | 27 | Same kinds of proof as everyone means the proof stops working as proof. It is scored on the kind of evidence, not on which customers are named. |
| Structure | 10% | 50 | The generic SaaS template — hero, logos, three-feature grid, testimonial, CTA. Familiar is not the same as memorable. |
| Visual | 5% | 57 | Weighted lowest on purpose: buyers rarely decide on this. Worth knowing, rarely worth fixing first. |

**Mostly the same** — Most of your claims are also theirs. Only the details differ.

## 2. Closest competitors

| Competitor | Same | Band |
| --- | --- | --- |
| Infinitus | 75 | Interchangeable |
| Ostro (Veeva) | 73 | Mostly the same |

_Measured from your side: how much of what YOU say each competitor also says, weighted by where you put it._

## 3. Ownable share

**The share of your own page's claim space that is yours to keep.** This is not the inverse of the Sameness Index — it is measured on your claims alone, so the two do not add up to 100 and are not meant to.

Only 6% of your page is unique, relevant to how buyers choose, and hard to copy. That is the number to move.

- **Distinctive message share:** 56% — prominent space spent on claims no competitor makes.
- **Ownable share:** 6% — the part of that which is also relevant to how buyers choose and hard to copy.

## 4. Where you sound like everyone else

Most of your set makes each of these and you are spending prominent space on them, ranked by how much. **These are not necessarily lines to delete** — some of what a page has to say is unavoidably shared, and claims about what kind of product you are were left out of this list for exactly that reason. The question each one raises is whether it has earned its space.

- **drives therapy starts and conversion** (Hero, 100% of the set) — also on Ostro (Veeva), Infinitus
  - _"Reduce friction across the prescription journey for patients and HCPs"_
- **healthcare compliance and safety controls** (Hero, 100% of the set) — also on Ostro (Veeva), Infinitus
  - _"Hipaa Compliant"_
  - Said your way: nobody else makes this exact claim, but everyone occupies the territory.
- **drives therapy starts and conversion** (Section, 100% of the set) — also on Ostro (Veeva), Infinitus
  - _"Guides patients from first question through care, cost clarity, and enrollment"_
- **healthcare compliance and safety controls** (Section, 100% of the set) — also on Ostro (Veeva), Infinitus
  - _"Ask questions and get trusted, med-legal-approved answers"_
- **increases patient and HCP engagement** (Section, 100% of the set) — also on Ostro (Veeva), Infinitus
  - _"Drives engagement"_
- **clinical and treatment support capabilities** (Section, 100% of the set) — also on Ostro (Veeva), Infinitus
  - _"Receive refill support and ongoing adherence reminders"_
- **clinical and treatment support capabilities** (Section, 100% of the set) — also on Ostro (Veeva), Infinitus
  - _"Find a nearby doctor or treatment center"_
  - Said your way: nobody else makes this exact claim, but everyone occupies the territory.
- **clinical and treatment support capabilities** (Section, 100% of the set) — also on Ostro (Veeva), Infinitus
  - _"Provide dosing guidelines and administration support"_
  - Said your way: nobody else makes this exact claim, but everyone occupies the territory.

## 5. Buried gold

Unique, relevant, and sitting in body copy. The cheapest wins here — you already have the differentiation and the page hides it.

- **Engages patients earlier in the journey** (Body, 0% of the set)
  - _"Engage patients earlier in the journey"_

## 6. Claim inventory

| Claim | Type | Placement | Common | Sayability | Relevant | Ownership |
| --- | --- | --- | --- | --- | --- | --- |
| AI engagement platform purpose-built for pharma brands | category | Hero | 100% | anyone | yes | Commodity |
| Removes friction/barriers across the prescription journey | outcome | Hero | 50% | anyone | yes | Contested |
| HIPAA compliant | quality | Hero | 0% | anyone | yes | Unique for now |
| Surfaces medication cost savings and financial assistance | capability | Hero | 50% | some | yes | Contested |
| Available across chat, voice, and SMS channels | capability | Hero | 0% | anyone | yes | Unique for now |
| Backed by named venture investors | proof | Hero | 0% | some | no | Unique and owned |
| Guides patients end-to-end from question to enrollment | outcome | Section | 100% | anyone | yes | Commodity |
| Real-time analytics on patient and HCP interactions | capability | Section | 100% | anyone | yes | Commodity |
| Answers questions with med-legal/MLR-approved content | capability | Section | 50% | some | yes | Contested |
| Increases patient/HCP engagement | outcome | Section | 50% | anyone | yes | Contested |
| Refill support and adherence reminders keep patients on therapy | capability | Section | 50% | anyone | yes | Contested |
| Replaces disconnected tools with one coordinated layer | category | Section | 50% | anyone | yes | Contested |
| Helps users find nearby providers or treatment centers | capability | Section | 0% | anyone | yes | Unique for now |
| Provides dosing and administration support | capability | Section | 0% | anyone | no | Unique for now |
| Provides guidance on starting therapy | capability | Section | 0% | anyone | yes | Unique for now |
| Top-performing website tactic engaging hundreds daily | proof | Section | 0% | anyone | no | Unique for now |
| Used by leading pharmaceutical brands | proof | Section | 0% | anyone | yes | Unique for now |
| Automates prior authorization and payor/pharmacy calls | capability | Section | 50% | some | yes | Contested |
| Cuts manual workload and speeds time to therapy | outcome | Section | 50% | some | yes | Contested |
| Captures prescriber info and routes requests | capability | Section | 0% | anyone | no | Unique for now |
| Completes benefit verification and explains coverage | capability | Section | 0% | some | yes | Unique and owned |
| Connects HCPs to medical science liaisons and resources | capability | Section | 0% | some | no | Unique and owned |
| Delivers measurable ROI | outcome | Section | 0% | anyone | yes | Unique for now |
| Processes sample requests and tracks delivery | capability | Section | 0% | some | no | Unique and owned |
| Reduces inbound support inquiries | outcome | Section | 0% | anyone | yes | Unique for now |
| Captures adverse events and pharmacovigilance reporting | capability | Section | 0% | some | yes | Unique and owned |
| High user satisfaction rate | outcome | Section | 0% | anyone | no | Unique for now |
| Converts digital demand into therapy starts | outcome | Body | 100% | anyone | yes | Commodity |
| Reduces bounce, abandonment, and drop-off | outcome | Body | 50% | anyone | yes | Contested |
| Engages patients earlier in the journey | outcome | Body | 0% | anyone | yes | Unique for now |
| Extends brand experiences beyond the website | capability | Body | 0% | anyone | no | Unique for now |
| Extends field rep reach without added headcount | capability | Body | 50% | anyone | yes | Contested |
| Integrates with existing enterprise systems | capability | Body | 50% | some | yes | Contested |
| Supports HCPs between rep visits / always available | capability | Body | 50% | anyone | yes | Contested |

## What we compared

- **The Rx Assistant** (your page) — https://therxassistant.com/
- **Ostro (Veeva)** — https://ostro.veeva.com/
- **Infinitus** — https://www.infinitus.ai/pharma-and-life-sciences/

## What this does and does not tell you

An AI read each page and wrote down the claims it makes, then grouped the claims that say the same thing. **No score in this report was written by a model** — every number is computed from those groupings in our own code, with the weights shown above.

## The only way to know if it matters

This report can tell you where your messaging overlaps. It cannot tell you whether a buyer would care, or which of your reasons to buy actually land. Put the page in front of real B2B buyers in your target market and ask them.

[Test it with real buyers](https://wynter.com)